razoxane has been researched along with African Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clauw, DJ; Natale, RB; Ruddon, RW; Wheeler, RH | 1 |
| Akutsu, M; Kano, Y; Miura, Y; Narita, T; Sakamoto, S; Suda, K; Suzuki, K | 1 |
2 other study(ies) available for razoxane and African Lymphoma
| Article | Year |
|---|---|
The cytokinetic and cytotoxic effects of ICRF-159 and ICRF-187 in vitro and ICRF-187 in human bone marrow in vivo.
Topics: Antineoplastic Agents; Bone Marrow Cells; Bone Neoplasms; Burkitt Lymphoma; Cell Cycle; Cell Division; Cell Survival; Cells, Cultured; Drug Evaluation; Humans; Kinetics; Lung Neoplasms; Mitosis; Piperazines; Razoxane; Stereoisomerism; Thymidine | 1983 |
The effects of ICRF-154 in combination with other anticancer agents in vitro.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cell Division; Cell Line; Dose-Response Relationship, Drug; Drug Interactions; Drug Screening Assays, Antitumor; Humans; Leukemia-Lymphoma, Adult T-Cell; Razoxane | 1992 |